News & Publications

• VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit Meetings
  Saratoga, CA - October 20, 2009 - VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular degeneration (AMD), today announced upcoming scientific and corporate presentations on its implantable telescope technology. VisionCare's investigational telescope implant is the first medical device to be recommended for FDA approval by the FDA Ophthalmic Devices Advisory Panel for End-Stage AMD, a leading cause of untreatable blindness in the U.S.
  Read More
  
  
• 03/30/09 - FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration
• 11/05/08 - Saratoga, CA – VisionCare Ophthalmic Technologies, Inc... today announced that the American Journal of Ophthalmology (AJO)... has published two-year results from the Phase II/III IMT002 trial showing substantial visual acuity improvement in End-Stage AMD patients.
• 04/22/08 - April 24th Meeting of Ophthalmic Devices Advisory Panel Postponed
• 05/01/07 - VisionCare Ophthalmic Technologies Announces Presentations on Implantable Telescope for End-Stage Macular Degeneration at ARVO Annual Meeting
• 04/25/07 - VisionCare Ophthalmic Technologies Announces Presentations at the American Society of Cataract and Refractive Surgery Annual Meeting
• 11/01/06 - Results of Implantable Telescope Trial Published in Ophthalmology Report on Vision and Quality of Life in Patients with End-Stage Age-Related Macular Degeneration
• 03/17/06 - VisionCare Ophthalmic Technologies Announces Presentations at the Annual Meeting of the American Society of Cataract and Refractive Surgery
• 10/19/05 - VisionCare Pivotal Study Shows Improved Vision and Quality of Life Outcomes in Patients with Age-Related Macular Degeneration
• 10/11/05 - VisionCare Announces Presentations on Pivotal Trial Results at the American Academy of Ophthalmology Annual Meeting
• 06/09/05 - VisionCare Appoints Joaquin Wolff Vice President of Global Marketing & Sales
• 06/08/05 - VisionCare Relocates and Expands Facility in Israel
• 06/06/05 - Michael J. Strauss, M.D., Joins VisionCare Board of Directors
• 01/04/05 - VisionCare Closes $20 Million Series D Financing
• Older press releases
  
  

Media Materials

Click here for VisionCare images and materials for download

Peer-Reviewed Publications Related to US Clinical Trials

Hudson HL, Stulting RD, Heier JS, Lane SS, Chang DF, Singerman LJ, Bradford CA, Leonard RE; IMT002 Study Group. Implantable Telescope for End-Stage Age-related Macular Degeneration: Long-term Visual Acuity and Safety Outcomes. Am J Ophthalmol. 2008:146;664-673.

Colby KA, Chang DF, Stulting RD, Lane SS. Surgical placement of an optical prosthetic device for end-stage macular degeneration: The Implantable Miniature Telescope. Arch Ophthalmol. 2007;125:1118-21.

Hudson HL, Lane SS, Heier JS, Stulting RD, Singerman L, Lichter PR, Sternberg P, Chang DF. Implantable miniature telescope for the treatment of visual acuity loss due to end-stage age-related macular degeneration: one-year results. Ophthalmology. 2006;113:1987-2001.

Lane, SS, Kuppermann, BD. The Implantable Miniature Telescope for macular degeneration. Curr Opin Ophthalmol. 2006;17:94-8.

Chun DW, Heier JS, Raizman MB. Visual prosthetic device for bilateral end-stage macular degeneration. Expert Rev Med Devices. 2005;2:657-65.

Lane SS, Kuppermann BD, Fine IH, Hamill MB, Gordon JF, Chuck RS, Hoffman RS, Packer M, Koch DD. A prospective multicenter trial to evaluate the safety and effectiveness of the implantable miniature telescope. Am J Ophthalmol 2004;137:993-1001.